Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Organon & Co.
< Previous
1
2
Next >
Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
December 12, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at the Piper Sandler 34th Annual Healthcare Conference
November 15, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the Third Quarter Ended September 30, 2022
November 03, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022
October 20, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)
August 17, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the Second Quarter Ended June 30, 2022
August 04, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate
July 28, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022
July 21, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates
June 13, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report
June 02, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the First Quarter Ended March 31, 2022
May 05, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
April 21, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
March 31, 2022
From
Organon & Co.
Via
Business Wire
Tickers
DARE
OGN
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021
February 17, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
February 16, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity
February 02, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022
February 01, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
January 05, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference
December 20, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Completes Acquisition of Forendo Pharma
December 13, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference
November 22, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the Third Quarter Ended September 30, 2021
November 11, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon to Acquire Forendo Pharma
November 11, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021
October 28, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women
October 15, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage
October 11, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy
September 21, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference
September 01, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at Citi’s 16th Annual BioPharma Virtual Conference
September 01, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the Second Quarter Ended June 30, 2021 and Announces Inaugural Dividend
August 12, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.